UK drug developer Adaptimmune fall after IPO prices at high end of expectations, raising $191M
ABC News: Top Stories, ABC News
Wed, 05/06/2015 - 1:42pm
UK drug developer Adaptimmune fall after IPO prices at high end of expectations, raising $191M